VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORKA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ORKAOruka Therapeutics, Inc.
$84.50$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksORKAQuarterly Financials

Oruka Therapeutics, Inc. (ORKA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Oruka Therapeutics, Inc. (ORKA) quarterly income statement — complete revenue, gross profit & net income history

ORKA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20Q1'20Q4'19Q3'19
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold43K28K00000019K28K28K27K19K17K16K26K26K25K24K22K
COGS % of Revenue--------------------
Gross Profit-43K-28K000000-19K-28K-28K-27K-19K-17K-16K-26K-26K-25K-24K-22K
Gross Margin %--------------------
Gross Profit Growth %----100%-----64.71%-75%-3.85%26.92%32%33.33%-18.18%-18.18%-19.05%-380%-266.67%
Operating Expenses36.39M34.4M34.1M28.43M25.09M38.33M29.45M21.49M2.46M3.25M5.65M4.69M4.82M4.08M5.11M1.96M1.28M1.31M1.25M1.23M
OpEx % of Revenue--------------------
Selling, General & Admin7.25M6.76M5.12M4.34M5.16M6M3.76M2.82M1.67M1.07M1.71M1.25M1.24M1.21M1.91M913K912K950K870K878K
SG&A % of Revenue--------------------
Research & Development29.14M27.64M28.99M24.09M19.93M32.33M25.69M18.67M165K2.18M3.94M3.44M3.58M2.88M3.2M1.05M372K365K384K347K
R&D % of Revenue--------------------
Other Operating Expenses00000000628K00000000000
Operating Income-36.43M-34.43M-34.1M-28.43M-25.09M-38.33M-29.45M-21.49M-2.48M-3.28M-5.68M-4.72M-4.84M-4.1M-5.13M-1.99M-1.31M-1.34M-1.28M-1.25M
Operating Margin %--------------------
Operating Income Growth %-45.24%10.17%-15.81%-32.27%-910.72%----20.11%-10.81%-136.98%-269.24%-206.12%-301.1%-59.58%13.13%24.76%16.31%24.97%
EBITDA-36.39M-34.4M-34.09M-28.41M-25.07M-38.31M-28.12M-22.24M-2.46M-3.25M-5.65M-4.69M-4.82M-4.08M-5.11M-1.96M-1.28M-1.31M-1.25M-1.23M
EBITDA Margin %--------------------
EBITDA Growth %-45.16%10.2%-21.22%-27.73%-917.86%----20.47%-10.61%-138.75%-275.23%-210.65%-307.5%-60.33%13.59%25.28%17.61%26.03%
D&A (Non-Cash Add-back)43K28K20K19K16K18.45K0019K28K28K27K19K17K16K26K26K25K24K22K
EBIT-36.43M-34.43M-30.28M-24.57M-21M-37.46M-28.12M-22.24M-2.01M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.31M-1.32M-1.24M-1.2M
Net Interest Income4.61M4.85M3.83M3.86M4.09M4.53M826K444K473K000000-2K-3K-4K0-1K
Interest Income4.61M4.85M3.83M3.86M4.09M4.53M1.33M444K473K00000000000
Interest Expense000000504K000000002K3K4K01K
Other Income/Expense4.61M4.85M3.83M3.85M4.09M4.94M826K-750K473K5K4K4K3K2K1K-1K-1K20K36K49K
Pretax Income-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.31M-1.32M-1.24M-1.2M
Pretax Margin %--------------------
Income Tax0000000000000000-9K0-16K-42K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0.69%0%1.29%3.51%
Net Income-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.3M-1.32M-1.23M-1.16M
Net Margin %--------------------
Net Income Growth %-51.53%11.41%-5.78%-10.48%-945.25%----20.2%-10.75%-136.66%-271.28%-210.61%-318.03%-72.23%9.33%20.67%17.66%27.43%
Net Income (Continuing)-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.3M-1.32M-1.23M-1.16M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.58-0.54-0.69-0.58-0.50-1.54-1.91-1.30-0.24-2.72-4.73-3.92-4.03-3.98-6.44-3.95-8.71-9.94-9.23-9.12
EPS Growth %-16%64.94%63.87%55.38%-108.33%----31.66%26.55%0.76%53.73%59.96%30.23%56.69%36.14%55.41%60.04%63.09%
EPS (Basic)-0.58-0.54-0.69-0.58-0.50-1.54-1.91-1.30-0.24-2.72-4.73-3.92-4.03-3.98-6.44-3.95-8.71-9.94-9.23-9.12
Diluted Shares Outstanding55.17M54.42M44.07M42.23M41.68M16.79M15.01M14.51M14.5M1.2M1.2M1.2M1.2M1.03M795.68K503.69K149.49K132.84K132.84K126.77K
Basic Shares Outstanding55.17M54.42M44.07M42.23M41.68M16.79M15.01M14.51M14.5M1.2M1.2M1.2M1.2M1.03M795.68K503.69K149.49K132.84K132.84K126.77K
Dividend Payout Ratio--------------------